Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Cancer”

1,034 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,034 results

Testing effectiveness (Phase 2)Study completedNCT03511391
What this trial is testing

CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors

Who this might be right for
Urothelial CarcinomaMelanomaRenal Cell Carcinoma+2 more
University Hospital, Ghent 99
Testing effectiveness (Phase 2)Ended earlyNCT02479178
What this trial is testing

BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Urothelial CarcinomaCholangiocarcinomaCervical Cancer+1 more
BIND Therapeutics 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT03854474
What this trial is testing

Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial Carcinoma

Who this might be right for
Locally Advanced Urothelial CarcinomaMetastatic Urothelial CarcinomaStage III Bladder Cancer AJCC v8+1 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Looking for participantsNCT04724018
What this trial is testing

Sacituzumab Govitecan Plus EV in Metastatic UC

Who this might be right for
Urothelial CancerMetastatic Urothelial CarcinomaMetastatic Urothelial Carcinoma of the Renal Pelvis and Ureter+1 more
Dana-Farber Cancer Institute 106
Testing effectiveness (Phase 2)WithdrawnNCT05234606
What this trial is testing

A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors

Who this might be right for
Urothelial CarcinomaTriple Negative Breast CancerNon-small Cell Lung Cancer+2 more
Silverback Therapeutics
Early research (Phase 1)Study completedNCT05524545
What this trial is testing

Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07)

Who this might be right for
Bladder CancerUrothelial Carcinoma
ALX Oncology Inc. 36
Testing effectiveness (Phase 2)WithdrawnNCT06018116
What this trial is testing

A Canadian Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer.

Who this might be right for
Metastatic Urothelial Carcinoma
CHU de Quebec-Universite Laval
Testing effectiveness (Phase 2)Looking for participantsNCT03609216
What this trial is testing

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Who this might be right for
Infiltrating Bladder Urothelial CarcinomaStage II Bladder Urothelial CarcinomaStage III Bladder Urothelial Carcinoma
Alliance for Clinical Trials in Oncology 271
Early research (Phase 1)Study completedNCT02482168
What this trial is testing

Study of the CD40 Agonistic Monoclonal Antibody APX005M

Who this might be right for
CancerNSCLCMelanoma+3 more
Apexigen America, Inc. 43
Large-scale testing (Phase 3)Study completedNCT01869413
What this trial is testing

Tranexamic Acid During Cystectomy Trial (TACT)

Who this might be right for
Bladder Cancer
Ottawa Hospital Research Institute 354
Testing effectiveness (Phase 2)Ended earlyNCT06171789
What this trial is testing

PRO1107 in Patients With Advanced Solid Tumors

Who this might be right for
Endometrial CancerOvarian CancerTriple Negative Breast Cancer+3 more
Genmab 33
Testing effectiveness (Phase 2)Study completedNCT03421652
What this trial is testing

Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemo

Who this might be right for
Stage II Bladder Urothelial Carcinoma AJCC v6 and v7Stage III Bladder Urothelial Carcinoma AJCC v6 and v7Stage IV Bladder Urothelial Carcinoma AJCC v7
Barbara Ann Karmanos Cancer Institute 20
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Not applicableLooking for participantsNCT07390617
What this trial is testing

Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma

Who this might be right for
NeuropathyUrothelial CarcinomaMetastatic Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT02006667
What this trial is testing

Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer

Who this might be right for
Urinary Tract Cancer
Hoffmann-La Roche 13
Large-scale testing (Phase 3)Looking for participantsNCT06774131
What this trial is testing

Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

Who this might be right for
Upper Urinary Tract Urothelial CarcinomaUrothelial Carcinoma
UroGen Pharma Ltd. 70
Not applicableNot Yet RecruitingNCT06798246
What this trial is testing

HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort Study

Who this might be right for
Upper Tract Urothelial Carcinoma
Peking University First Hospital 200
Testing effectiveness (Phase 2)Study completedNCT01261728
What this trial is testing

Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Study completedNCT03914794
What this trial is testing

Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors

Who this might be right for
Bladder CancerNMIBCNon-Muscle Invasive Bladder Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Post-approval studies (Phase 4)Not Yet RecruitingNCT05488353
What this trial is testing

A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma

Who this might be right for
Bladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 48
Load More Results